Update on the prophylaxis of migraine

Current Treatment Options in Neurology

Volumn 10, Issue 1, 2008, Pages 20-29

  Schürks, Markus ^a   Diener, Hans Christoph ^a   Goadsby, Peter ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ACETYLSALICYLIC ACID; AMITRIPTYLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BOTULINUM TOXIN A; CANDESARTAN; FLUNARIZINE; GABAPENTIN; LISINOPRIL; MAGNESIUM; METHYSERGIDE; METOPROLOL; NADOLOL; NIMODIPINE; PETASITES HYBRIDUS EXTRACT; PIZOTIFEN; PLACEBO; PROPRANOLOL; RIBOFLAVIN; RIZATRIPTAN; TANACETUM PARTHENIUM EXTRACT; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UBIDECARENONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VERAPAMIL; ZONISAMIDE;

ABDOMINAL PAIN; ACUPUNCTURE; ADD ON THERAPY; AEROBIC EXERCISE; ALOPECIA; ANTICHOLINERGIC SYNDROME; BLOOD PRESSURE; BRADYCARDIA; BRAIN HYPOXIA; BRONCHOSPASM; CHRONIC TENSION HEADACHE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CLUSTER HEADACHE; COGNITIVE DEFECT; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; COUGHING; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM ULCER; DIZZINESS; DRUG ANTAGONISM; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; EXCITABILITY; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL PAIN; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE FIBROSIS; HUMAN; HYPERKINESIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INCREASED APPETITE; IRRITABILITY; LIFESTYLE MODIFICATION; LIVER DYSFUNCTION; LOW DRUG DOSE; LUNG FIBROSIS; MEMORY DISORDER; METABOLIC ACIDOSIS; MIGRAINE; MYALGIA; NAUSEA; NEPHROLITHIASIS; PARESTHESIA; PARKINSONISM; PROSTATE ADENOMA; PSYCHOSIS; RELAXATION TRAINING; RETROPERITONEAL FIBROSIS; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; SUDDEN DEATH; TASTE DISORDER; TRANSFORMED MIGRAINE; TREMOR; UNSPECIFIED SIDE EFFECT; URINE RETENTION; VALVULAR HEART DISEASE; VISUAL IMPAIRMENT; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

EID: 38749084121     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-008-0003-3     Document Type: Review

References (53)

1. Lipton RB, Bigal ME, Diamond M, et al.: Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68:343-349.
2. Limmroth V, Michel MC: The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers. Br J Clin Pharmacol 2001, 52:237-243.
3. Holroyd KA, Penzien DB, Cordingley GE: Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991, 31:333-340.
4. Solomon GD, Steel JG, Spaccavento LJ: Verapamil prophylaxis of migraine: a double-blind, placebo-controlled study. JAMA 1983, 250:2500-2502.
5. Brandes J, Saper J, Diamond M, et al.: Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004, 291:965-973.
6. Diener HC, Tfelt-Hansen P, Dahlöf C, et al.: Topiramate in migraine prophylaxis: results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004 251:943-950.
7. Silberstein SD, Neto W, Schmitt J, et al.: Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004, 61:490-495.
8. Limmroth V, Biondi D, Pfeil J, Schwalen S: Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Headache 2007, 47:13-21.
9. Diener HC, Bussone G, Van Oene J, et al.: Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007, 27:814-823.
10. Silberstein SD, Lipton RB, Dodick DW, et al.: Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007, 47:170-180.
11. Silberstein SD, Feliu AL, Rupnow MF, et al.: Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost. Headache 2007, 47:500-510.
12. Steiner TJ, Findley LJ, Yuen AWC: Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 1997, 17:109-112.
13. Lampl C, Katsarava Z, Diener HC, Limmroth V: Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 2005, 76:1730-1732.
14. Mathew NT, Rapoport A, Saper J, et al.: Efficacy of gabapentin in migraine prophylaxis. Headache 2001, 41:119-128.
15. Drake ME Jr. Greathouse NI, Renner JB, Armentbright AD: Open-label zonisamide for refractory migraine. Clin Neuropharmacol 2004, 27:278-280.
16. Pakalnis A, Kring D: Zonisamide prophylaxis in refractory pediatric headache. Headache 2006, 46:804-807.
17. Ashkenazi A, Benlifer A, Korenblit J, Silberstein SD: Zonisamide for migraine prophylaxis in refractory patients. Cephalalgia 2006, 26:1199-1202.
18. Silberstein SD: Methysergide. Cephalalgia 1998, 18:421-435.
19. Cerbo R, Casacchia M, Formisano R, et al.: Flunarizinepizotifen single-dose double-blind cross-over trial in migraine prophylaxis. Cephalalgia 1986, 6:15-18.
20. Diener HC, Hartung E, Chrubasik J, et al.: A comparative study of acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomised, controlled, double-blind, parallel group phase III study. Cephalalgia 2001, 21:140-144.
21. Welch KMA: Naproxen sodium in the treatment of migraine. Cephalalgia 1986, 6:85-92.
22. Couch JR, Hassanein RS: Amitriptyline in migraine prophylaxis. Arch Neurol 1979, 36:695-699.
23. Ziegler DK, Hurwitz A, Hassanein RS, et al.: Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol 1987, 44:486-489.
24. Ozyalcin SN, Talu GK, Kiziltan E, et al.: The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005, 45:144-152.
25. Kuritzky A, Zoldan Y, Melamed E: Selegeline, a MAO B inhibitor, is not effective in the prophylaxis of migraine without aura - an open study. Headache 1992, 32:416.
26. Moja PL, Cusi C, Sterzi RR, Canepari C: Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005:CD002919.
27. Schrader H, Stovner LJ, Helde G, et al.: Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001, 322:19-22.
28. Tronvik E, Stovner L, Helde C, et al.: Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003, 289:65-69.
29. Charles JA, Jotkowitz S, Byrd LH: Prevention of migraine with olmesartan in patients with hypertension/prehypertension. Headache 2006, 46:503-507.
30. Grossmann M, Schmidramsl H: An extract of Petasites hybridus is effective in the prophylaxis of migraine. Inter J Clin Pharmacol Therapeutics 2000, 38:430-435.
31. Diener HC, Rahlfs VW, Danesch U: The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 2004, 51:89-97.
32. Lipton RB, Gobel H, Einhaupl KM, et al.: Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 2004, 63:2240-2244.
33. Diener HC, Pfaffenrath V, Schnitker J, et al.: Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention - a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 2005, 25:1031-1041.
34. Pfaffenrath V, Diener HC, Fischer M, et al.: on behalf of the Investigators. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis - a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002, 22:523-532.
35. Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine - a double-blind placebo-controlled study. Phytother Res 1997, 11:508-511.
36. Murphy JJ, Heptinstall S, Mitchell JRA: Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988, 2:189-192.
37. Johnson ES, Kadam NP, Hylands DM, Hylands PJ: Efficacy of feverfew as a prophylactic treatment of migraine. BMJ 1985, 291:569-573.
38. Peikert A, Wilimzig C, Köhne-Volland R: Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996, 16:257-263.
39. Pfaffenrath V, Wessely P, Mener C, et al.: Magnesium in the prophylaxis of migraine - a double-blind placebo-controlled study. Cephalalgia 1996, 16:436-440.
40. Schoenen J, Jacquy J, Lenaerts M: Effectiveness of high-dose riboflavin in migraine prophylaxis - a randomized controlled trial. Neurology 1998, 50:466-470.
41. Sandor PS, Di Clemente L, Coppola G, et al.: Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005, 64:713-715.
42. Magis D, Ambrosini A, Sandor P, et al.: A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache 2007, 47:52-57.
43. Aurora SK, Gawel M, Brandes JL, et al.: Botulinum toxin type A prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Headache 2007, 47:486-499.
44. Elkind AH, O'Carroll P, Blumenfeld A, et al.: A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis. J Pain 2006, 7:688-696.
45. Evers S, Vollmer-Haase J, Schwaag S, et al.: Botulinum toxin A in the prophylactic treatment of migraine - a randomized, double-blind, placebo-controlled study. Cephalalgia 2004, 24:838-843.
46. Relja M, Poole AC, Schoenen J, et al.: A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Cephalalgia 2007, 27:492-503.
47. Silberstein S, Mathew N, Saper J, Jenkins S: Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 2000, 40:445-450.
48. Diener HC, Kronfeld K, Boewing G, et al.: Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 2006, 5:310-316.
49. Linde K, Streng A, Jurgens S, et al.: Acupuncture for patients with migraine: a randomized controlled trial. JAMA 2005, 293:2118-2125.
50. Alecrim-Andrade J, Maciel-Junior JA, Cladellas XC, et al.: Acupuncture in migraine prophylaxis: a randomized sham-controlled trial. Cephalalgia 2006, 26:520-529.
51. Ernst E: Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manage 1999, 18:353-357.
52. Campbell J, Penzien DB, Wall EM: Evidence-based guidelines for migraine headache: behavioral and physical therapy. Available at http://www.aan.com/professionals/practice/pdfs/g10089.pdf. Accessed July 2007.
53. Köseoglu E, Akboyraz A, Soyuer A, Ersoy AO: Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia 2003, 23:972-976.